Wolfgang Jarolimek Selected Research

human AOC3 protein

7/2017	Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.
3/2015	Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang Jarolimek Research Topics

Disease

11	Fibrosis (Cirrhosis) 01/2023 - 11/2013
5	Inflammation (Inflammations) 01/2021 - 11/2013
3	Cicatrix (Scar) 01/2023 - 01/2021
2	Neoplasms (Cancer) 01/2023 - 04/2017
2	Primary Myelofibrosis (Myelosclerosis) 05/2022 - 12/2019
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2022 - 01/2018
2	Infections 03/2015 - 01/2013
2	Pneumonia (Pneumonitis) 03/2015 - 11/2013
1	Adenocarcinoma 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Systemic Scleroderma (Systemic Sclerosis) 05/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Albuminuria 01/2020
1	Cytopenia 12/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 07/2017
1	Neuroinflammatory Diseases 07/2017
1	Breast Neoplasms (Breast Cancer) 04/2017
1	Sepsis (Septicemia) 03/2015
1	Asthma (Bronchial Asthma) 03/2015
1	Lung Diseases (Lung Disease) 03/2015
1	Ureteral Obstruction 10/2014
1	Disease Progression 01/2013
1	Cystic Fibrosis (Mucoviscidosis) 01/2013

Drug/Important Bio-Agent (IBA)

7	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 11/2013
6	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2023 - 04/2017
5	CollagenIBA 05/2022 - 01/2018
5	EnzymesIBA 01/2022 - 10/2014
4	Amine Oxidase (Copper-Containing)IBA 01/2020 - 11/2013
3	AminesIBA 04/2017 - 11/2013
2	ElastinIBA 05/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 10/2014
2	human AOC3 proteinIBA 07/2017 - 03/2015
2	4- (2- (aminomethyl)- 3- fluoroallyloxy)benzenesulfonamideIBA 07/2017 - 11/2013
1	Fibrillar CollagensIBA 01/2023
1	Gemcitabine FDA Link 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2022
1	Calcineurin InhibitorsIBA 01/2021
1	NitrogenIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021
1	ruxolitinibIBA 12/2019
1	ProdrugsIBA 11/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2019
1	pyridinolineIBA 01/2018
1	LipopolysaccharidesIBA 07/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2017
1	mannose-6-phosphateIBA 06/2015
1	PXS-4728AIBA 03/2015
1	LigandsIBA 03/2015
1	Messenger RNA (mRNA)IBA 10/2014
1	CytokinesIBA 10/2014
1	3-nitrotyrosineIBA 10/2014
1	CopperIBA 11/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2013
1	Interleukin-6 (Interleukin 6)IBA 11/2013
1	AminoglycosidesIBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2013
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2013

Therapy/Procedure

2	Therapeutics 04/2017 - 01/2013
1	Drug Therapy (Chemotherapy) 01/2023
1	Stem Cell Transplantation 12/2019
1	Injections 07/2017
1	Ligation 03/2015
1	Punctures 03/2015